Investing News NetworkYour trusted source for investing success

g1 therapeutics

G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib

G1 Therapeutics Releases Phase 2 Data

G1 Therapeutics Announces Positive Myelopreservation Data

8 Top Gains and Losses at 2018’s ESMO Event

G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer

G1 Therapeutics Announces Pricing of Offering of Common Stock

G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data

G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights

G1 Therapeutics Closes IPO

G1 Releases Details of Upcoming IPO

Blackstone Secures $22.6m for Mankayan Copper-Gold Drilling

C29 Metals shifts focus to Mayfield Copper Project

Equity Metals: Advancing High-grade, District-scale Silver and Gold Assets in British Columbia

South Harz Potash: A Globally Significant European Potash and Critical Minerals Opportunity

Ian Rodger Appointed Managing Director

South Harz Potash Limited

Equity Metals

Terra Clean Energy

BP

NevGold

FinEx Metals

MARKETS

COMMODITIES

CURRENCIES